Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Road Walker who wrote (362601)	12/13/2007 10:52:45 AM
From: tejek	Respond to of 1587370

This may be why the Feds only cut a 1/4 pt. Wholesale Prices, Retail Sales Jump ap.google.com

To: Road Walker who wrote (362601)	12/13/2007 3:04:32 PM
From: tejek	Respond to of 1587370

It seems the FDA is playing politics with our health. Congress Asked to Probe Denial of Dendreon Drug By Mike Huckman, CNBC Pharmaceutical Reporter \| 13 Dec 2007 \| 01:44 PM ET Dendeon shares surged after three members of Congress asked for an investigation of a Food and Drug Administration panel's vote against the pharmaceutical company's prostate cancer drug. The congressional trio asked Rep. John Dingell, chairman of the House Energy and Commerce Committee, to probe allegations of conflicts of interest and ethical violations of at least two FDA advisory committee members that opposed approval of Provenge. There was no word from Dingell's office on whether the investigation will proceed, but investors sent Dendreon shares up 18 percent following a CNBC report on the matter. © 2007 CNBC.comhttp://www.cnbc.com/id/22245755/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahoo